Abstract

BackgroundEffective therapeutic options are limited for the management of chronic central serous chorioretinopathy (CSCR) complicated by exudative retinal detachments (RD). The authors describe the resolution of one such case following partial thickness scleral resection with mitomycin C.Case presentationThis 39-year-old male presented with a unilateral inferior exudative RD in the right eye. There was no history of steroid use either locally or systemically. The fundus fluorescein angiogram showed window defects and leaks typical of chronic CSCR. The axial length was 21.06 mm in the right eye and 21 mm in the left eye. Thickening of the ocular coats was evident on ocular ultrasound. Considering an axial length in the borderline-low range inferotemporal and inferonasal partial thickness scleral resection with mitomycin C was performed. The exudative RD resolved at 4 months.ConclusionPartial thickness scleral resection may be considered as an option for treating chronic CSCR patients with borderline-low axial length complicated by exudative RD.

Highlights

  • Effective therapeutic options are limited for the management of chronic central serous chorioretinopathy (CSCR) complicated by exudative retinal detachments (RD)

  • Gass JD hypothesized that the hampered permeability of the sclera to protein rich subretinal and suprachoroidal fluid is the cause of uveal effusion syndrome (UES) and that the ‘barrier effect of the sclera is more important than vortex vein obstructing effect’ [9]

  • UES with nanophthalmos benefits from sclerectomy [10] as thick and abnormal sclera is present in such cases

Read more

Summary

Conclusion

Partial thickness scleral resection may be considered as an option for treating chronic CSCR patients with borderline-low axial length complicated by exudative RD. Keywords: Nanophthalmos, Uveal effusion syndrome, Diffuse retinal pigment epitheliopathy, Sclerectomy

Background
Findings
Conclusions
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call